Definium Therapeutics, Inc.

SEC 4 · Filed

0001193125-26-126830Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Mar 25, 2026

Sale by Karlin Daniel

Security
Common Shares
Code
S
Shares
8,018
Price per share
18.47
Structured facts
{
  "code": "S",
  "date": "2026-03-25",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Represents the number of Common Shares sold to satisfy withholding tax obligations in connection with the settlement of vested restricted stock units, pursuant to sell-to-cover elections under a Rule 10b5-1 plan adopted on June 14, 2022.",
    "F2": "The reported price is a weighted average sales price. These shares were sold in multiple transactions on March 25, 2026 at prices ranging from $18.36 to $18.80. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.",
    "F3": "Amount includes 1,586 shares acquired under the Definium Therapeutics, Inc. 2024 Employee Share Purchase Plan."
  },
  "owners": [
    {
      "cik": "0001897618",
      "name": "Karlin Daniel",
      "roles": [
        "officer"
      ],
      "title": "Chief Medical Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "413317",
  "price": "18.47",
  "row": 1,
  "rule_10b5_1": "true",
  "security": "Common Shares",
  "shares": "8018",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}